About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Tennessee | 18,974 Studies Near You

Clinical TrialsTennessee

Clinical Trials in Tennessee

Discover 18,974 clinical trials near Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4201-4220 of 18,974 trials

RecruitingA Research Study to Advance the CF Therapeutics Pipeline for People Without ModulatorsThe REACH study is for people with CF who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators.NCT06504589·Birmingham, Alabama and 67 others

Find Trials by Condition in Tennessee

Breast Cancerin Tennessee Lung Cancerin Tennessee Prostate Cancerin Tennessee Colorectal Cancerin Tennessee Melanomain Tennessee Leukemiain Tennessee Lymphomain Tennessee Pancreatic Cancerin Tennessee Ovarian Cancerin Tennessee Brain Cancerin Tennessee

Data from ClinicalTrials.govTerms

CompletedTreatment for Teachers With Vocal FatigueTeachers are a population at high risk for voice disorders given their occupational demands.NCT04486989·Johnson City, Tennessee

CompletedCombination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic LeukemiaThis phase III trial is studying combination chemotherapy to see how well it works in treating young patients with newly diagnosed acute promyelocytic leukemia.NCT00866918·Birmingham, Alabama and 120 others

CompletedScoring System for Inhalation InjuryThe goal of this multicenter study is to develop a standardized scoring system for inhalation injury that can be used both to quantify and predict injury severity inhalation…NCT01194024·Phoenix, Arizona and 8 others

CompletedSafety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL)The purpose of the UNIVERSAL study is to assess the safety, efficacy, cell kinetics, and immunogenicity of ALLO-715 with or without Nirogacestat in adults with relapsed or…NCT04093596·Gilbert, Arizona and 10 others

CompletedA Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset SeizuresThis study evaluated the efficacy and safety of two trough-ranges of everolimus given as adjunctive therapy in patients with tuberous sclerosis complex (TSC) who had refractory…NCT01713946·Birmingham, Alabama and 103 others

SuspendedIberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple MyelomaThis phase II trial compares iberdomide maintenance therapy to disease monitoring for improving survival in patients who have received idecabtagene vicleucel (a type of chimeric…NCT06179888·Irvine, California and 73 others

CompletedStudy to Evaluate Safety and Efficacy of Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye DiseasePrimary Objectives: * To compare the efficacy of cenegermin vs vehicle in Schirmer I test (without anaesthesia) \> 10 mm/5 min at Week 4 by testing the superiority.NCT05136170·Glendale, California and 9 others

TerminatedAssessing Normal Multichannel Intraluminal Impedance (MII)-pH Parameters for Today's PopulationThe normal values of a Multichannel Intraluminal Impedance (MII)-pH study can vary between ages, gender, race and different values of body mass index (BMI).NCT01566383·Nashville, Tennessee and 1 other

CompletedA Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1The purpose of this study was to evaluate the safety, tolerability, and pharmacokinetics (PK) of dolutegravir (DTG) in infants born to mothers living with HIV-1.NCT05406583·Los Angeles, California and 14 others

CompletedPrevention of Recurrence of DiverticulitisThe purpose of this study is to determine whether SPD476 is effective in reducing recurrence of diverticulitis.NCT00545740·Litchfield Park, Arizona and 120 others

Active not recruitingAutonomic Determinants of POTS - Pilot1Postural tachycardia syndrome (POTS) is a relatively common condition affecting mostly otherwise healthy young women.NCT04050410·Nashville, Tennessee

CompletedOpen-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease PsychosisTo assess the effect of pimavanserin on the activities of daily living in subjects with Parkinson's Disease PsychosisNCT04292223·Scottsdale, Arizona and 17 others

CompletedIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaRATIONALE: Intravenous VEGF Trap may stop the growth of solid tumors or non-Hodgkin's lymphoma by stopping blood flow to the cancer.NCT00082823·New York, New York and 1 other

CompletedA Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)The primary purpose of this study is to assess the efficacy and safety of the etonogestrel (ENG) contraceptive implant during participants' fourth and fifth years of use when used…NCT04626596·Birmingham, Alabama and 66 others

CompletedA Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors* To evaluate the safety and tolerability of escalating doses of ERAS-601 when administered as a monotherapy and in combination with other cancer therapies in study participants…NCT04670679·Birmingham, Alabama and 13 others

RecruitingA Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 MutationsThis phase III trial compares standard chemotherapy to therapy with liposome-encapsulated daunorubicin-cytarabine (CPX-351) and/or gilteritinib for patients with newly diagnosed…NCT04293562·Birmingham, Alabama and 205 others

CompletedA Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222This study will evaluate the safety, tolerability, and efficacy of ABBV-3067 given alone and in combination with various doses of ABBV-2222 in adults with Cystic Fibrosis who are…NCT03969888·Little Rock, Arkansas and 50 others

CompletedA Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.The participants in this study will have confirmed PBC with inadequate response or intolerance to Ursodeoxycholic acid (UDCA), which is a medication used in the management and…NCT06383403·Coronado, California and 59 others

TerminatedAdenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.Phase II, randomized, safety and efficacy study in recurrent/metastatic breast cancer with accessible lesions.NCT01703754·Jacksonville, Florida and 7 others

PreviousPage 211 of 949Next

Diabetes

in Tennessee

Heart Diseasein Tennessee